Recurrent Leiomyosarcoma
2 clinical trials · Condition
◉ Watch Recurrent Leiomyosarcoma
| Record | Firm | Date |
|---|---|---|
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
| Alisertib in Treating Patients With Advanced or Metastatic Sarcoma (NCT01653028) | National Cancer Institute (NCI) | 2012-08-22 |
Track Recurrent Leiomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.